Magazine Article | July 1, 2020

3 Essential Considerations For Running Global Clinical Trials

Source: Life Science Leader

By Roger Tell, M.D., Ph.D.

In recent years, global clinical trials have become standard, and for a good reason. In broad terms, expanding clinical trials across the world gives the investigational drug better opportunity to demonstrate its true impact.

Global clinical trials offer key advantages to patients and industry; however, smaller companies may be hesitant to partake, wondering if the inevitable challenges outweigh the benefits. Companies with limited resources may struggle to handle relationships among necessary external contacts, including CROs, investigators, and regulatory agencies. Throughout my career as an oncologist and in my role as the chief medical officer at Isofol Medical, a Swedish biotech company running a global Phase 3 clinical trial in advanced colorectal cancer, I’ve become familiar with several best practices to overcome many of these issues.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: